Figure 3.

Insulin dose at end‐of‐trial according to baseline HbA1c category in DUAL I (A) and DUAL II (B). Data are mean dose (U) from the safety analysis set, last observation carried forward. Error bars are standard error of the mean. EOT, end‐of‐trial; IDeg, insulin degludec; IDegLira, insulin degludec/liraglutide combination.